of hemorrhage. 5 The agents for sclerotherapy are 5% Sodium Morruhate, 1% Polidocal, Sodium Tertradecil Sulfate, Absolute Alcohol and 5% Ethanol Amine Oleate. 6 No clinical studies are found which compare the effectiveness of various sclerosing agents. However, Ethanol Amine Oleate (EAO) is a sclerosing agent accepted for skin vascular lesions and oesophageal varices. Nevertheless, few studies deal with Ethanol Amine Oleate efficacy in head and neck vascular lesions particularly oral and perioral lesions. 3 An open clinical trial was conducted for the first time by Johann et al. in 2005 to support the use of a secure and easy application of Ethanol Amine Oleate in the treatment of 30 Benign Oral Vascular Lesions.
With this idea, the purpose of this study was to evaluate the effectiveness of Ethanol Amine Oleate in the management of Benign Oral and Perioral Vascular Lesions as a sclerosing agent.
Methods:
The proposed study was presented in front of the Ethical Review Committee, BSMMU and the ethical clearance was achieved.
The cases were selected irrespective of age, gender, religion or socioeconomic status of the patient considering the inclusion and exclusion criteria. 32 cases were selected based on history, clinical examination and imaging techniques like Colour Doppler, CT scan, MRI and /or Angiography.
Informed written consent were taken from the patient or legal guardians after duly informing about the procedure of the treatment, anticipated result and possible advantages, disadvantages and complications considering all ethical issues. Photographs of the lesion were taken. Injection 5% Ethanol Amine Oleate diluted with distilled water in a ratio 1:1 was given intralesionally. The dose was adjusted according to the site and size of the lesion and weight of the patients. Injection was pushed directly into the lesion on multiple sites with 23G or Hypodermic needle until slight elevation of the lesion. The patients were observed on 3 rd and 7 th day and advised to report if any complications arise. In case with small lesions, where a single session was adequate, follow up were given after 8 weeks for evaluation of the effect of Ethanol Amine Oleate and reduction of size of Vascular Lesion.
In case with large diffuse lesions where single session was not adequate, patients were advised to attend after 2 weeks interval for 2 nd and subsequent procedure. Follow up was given after 8weeks of the last session to evaluate the effect of Ethanol Amine Oleate.
Patients were examined for all the parameters that were used to access the lesion pre-operatively and data collected in data collection sheet. Further follow up of the patients were done up to 6 months for any recurrence or complications.
Photographs were also taken during each follow up session to document the effect of injections. Chi-square test and ANOVA test were done to assess the significance. The values of p<0.05 were considered statistically significant. Data analysis was conducted using SPSS software.
Results:
The patient in this study consisted of 24 males and 8 females with male to female ratio of approximately 3:1. The mean age of the patient was 19 years ± 11 with a range of 1 ½ to 40 years and 31.7% of them were in 21-30 years of age group (Table-I ). In a total of 32 lesions, 7 lesions (21.9%) were found in tongue and upper lip each, which was followed in order of frequency by the buccal mucosa (6 lesions), cheek ( 6 lesions), lower lip (3 lesions), floor of the mouth (2 lesions) and soft palate (1 lesion). On Colour Doppler, 9 lesions were classified to have arterial flow, 8 had venous flow and 7 had both arterial and venous flow ( Table-II) . Table- IV shows the outcomes according to size of the lesion of the patients. The mean (±SD) size of the lesion was 2.1±1.8 cm with ranged from 1 -7 cm of excellent recovery patients, 4.6±2.3 cm with ranged from 2.5 -10 cm in good, 7.0±4.2 cm with ranged from 4 -10 cm in fair, 5.0 cm in two patients of poor recovery, and both patients had 2 cm lesions size. Significant mean size of the lesions differences were found in different outcome in ANOVA test. The outcome of the Sclerotherapy was: 11 (34.4%) had excellent result, 17 (53.1%) had good result, 2 (6.3%) had fair result and 2 (6.3%) had poor result (Fig.-1) & photograph.
Discussion:
Presentation of vascular lesions varies with age, size and anatomic location, and there are no known parameters to assess therapeutic efficacy. 8 Thus, it is difficult to evaluate the results after the treatment of vascular lesions. This study has tried to objectively evaluate the results on clinical basis aided by comparison of pre-treatment and post-treatment photographs. This study has also attempted to study factors that might predict the result of Sclerotherapy. The study has analyzed the possible association of variables, such as age and sex of the patient, size, age of onset and type of flow of the VLs with the result of Sclerotherapy.
Sclerotherapy is a very conventional method in the treatment of vascular lesions. However, it still is considered as an extremely durable and versatile treatment modality due to its ease, simplicity and safety. The procedure can be repeated as often as it is necessary with minimal complications. Even when Sclerotherapy just reduces the size, it provides a best complement to subsequent surgery.
It decreases the lesion size and changes its nature to more fibrous consistency; resection is therefore accomplished with minimal blood loss. 9 Johann et al., in 2005 carried out a study in 30 lesions, in which all patients responded to the treatment with total resolution. Similarly in the study by Kaji In present study , Table IV shows significant mean size of the lesions differences in different outcome in ANOVA test. This meant that VLs with smaller size responded better to Sclerotherapy than those with larger size. This finding could be considered supported by de Lorimier, 1995 13 where he had mentioned that permanent obliteration is easier to achieve in small-diameter vessels than in widely dilated channels. A case study reported by Choi et al., 2002 10 , also mentioned that Sclerotherapy is most effective when the vascular spaces are small or when blood flow is slow. Therefore, it is advisable to begin Sclerotherapy as early as possible once the diagnosis is made.
Photograph-1: Effectiveness of Sclerotherapy after 8 weeks of Sclerotherapeutic session (n=32)

Photograph-2: Photographic Demonstration of a patient Undergoes for Sclerotherapy
Similarly, In Colour Doppler findings significant differences were found only in lesions with both arterial and venous type of flow.
Perhaps, our failure to statistically support correlation of all the parameters with the outcome of the Sclerotherapy can be ascribed to small size of our samples. Interpretation of the findings must also take into account the fact that Vascular Anomalies evolve and that some patients in this study will require further Sclerotherapy.
Conclusion:
Sclerotherapy with Ethanol Amine Oleate is a safe and less invasive method, easy to perform repeatedly with minimal risk to the patient. Procedure related complications like induration, swelling, pain and cutaneous or mucosal blistering at the site of injection can occur in some patients. However, these complications are minor and will usually subside in 3-4 days.
Thus intralesional Sclerotherapy with EAO can be the treatment of choice for symptomatic Vascular lesions.
